Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
批准号:
10725416
负责人:
Chang Liu
金额:
$46.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-01 至 2028-07-31
关键词:
2019-nCoV3&apos Untranslated Regions5&apos Untranslated RegionsActive SitesAddressAffectAffinity ChromatographyAntiviral AgentsAntiviral ResponseBindingBiologicalBiological ModelsBiological ProcessBiologyBiophysicsCOVID-19 pandemicCOVID-19 therapeuticsCellsColorCommunicable DiseasesComplexCoronavirusCryo-electron tomographyCryoelectron MicroscopyDNA-Directed RNA PolymeraseDepositionDevelopmentDrug resistanceEconomicsFutureGPRC5C geneGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGoalsHost Defense MechanismIn SituIntegration Host FactorsInterferonsInterventionKineticsKnowledgeLife Cycle StagesLinkMass Spectrum AnalysisMediatingMethyltransferaseModificationMolecularOutcomePathogenesisPathogenicityProcessProteinsRNA BiochemistryRNA Polymerase InhibitorRNA VirusesRNA chemical synthesisRNA-Directed RNA PolymeraseRegulationReplication-Associated ProcessRepliconReporterResearchRoleSARS-CoV-2 genomeSignal PathwayStreamSurfaceSystemTherapeuticTimeTranscription InitiationTranscription ProcessTranslationsTretinoinVaccinesViralViral GenesViral PathogenesisVirusVirus DiseasesVirus ReplicationVisualizationWorkarms racebiochemical toolscoronavirus therapeuticsdesignexperimental studyglobal healthhuman coronavirusinnovationmutantnew therapeutic targetnovelnovel coronavirusnovel strategiesnovel therapeuticspandemic diseaseprogramsreconstitutionreconstructionresearch and developmentsensorsingle moleculesingle-molecule FRETstructural biologysuccesstargeted agenttherapeutic developmenttherapeutically effectivetoolviral RNAvirologyvirus host interaction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Over the last two decades, three highly pathogenic human coronaviruses, including SARS-CoV-2, have
emerged, arguing that future deadly pandemics of new or re-emerging coronaviruses and other RNA viruses are
almost inevitable. The urgent need to treat these fatal infectious diseases has prioritized the discovery and
development of novel effective antivirals. However, despite the unprecedented efforts to address the COVID-19
crisis, highly effective COVID-19 therapeutics are severely limited due to the lack of a mechanistic understanding
of coronavirus replication and pathogenesis. Most of the current research and therapeutic development efforts
focus on SARS-CoV-2 RNA polymerase (RdRp) or spike protein, but their success can be severely undermined
by a unique SARS-CoV-2 proofreading mechanism that excises incorporated RdRp inhibitors or by the rapid
emergence of drug-resistant spike protein mutants. Therefore, it is imperative to develop innovative antiviral
strategies targeting distinct, and in some cases yet to be identified, essential components of the viral life cycle.
The intricate virus-host interplay constitutes a sophisticated regulatory network that dictates the outcome of virus
infection, affording promising opportunities to be explored for innovative antiviral therapeutics. However, current
knowledge of coronavirus-host interactions is mostly limited to the virus-host arms race in activating or blocking
the interferon-dependent signaling pathways or in competing for host translation machinery. By contrast, virus-
host interplay in coronavirus gene expression and regulation is largely uncharted territory. This major gap greatly
hinders the design of novel antiviral agents targeting these much-overlooked coronavirus-host interactions that
are critical for viral survival and host antiviral responses. The central objectives of this proposal are to define
novel molecular mechanisms and functional roles of multiple recently discovered SARS-CoV-2-host interactions
in modulating the viral replication and transcription processes and to identify new SARS-CoV-2-host interactions
linked to novel mechanisms of viral gene regulation. With a combination of structural biology, protein-RNA
biochemistry, single-molecule biophysics, cell virology, and computational approaches, we will accomplish these
tasks through three tightly interwoven aims. In Aim 1, we will determine the molecular and structural basis of
these newfound interactions between host factors and the viral replication-transcription machinery. In Aim 2, we
will delineate the biological functions of these crucial host factors in modulating viral replication and transcription.
In Aim 3, we will develop an innovative capture-identification-visualization experimental pipeline to discover new
host factors and novel viral replication-transcription-regulating mechanisms. Together, these studies will
establish an innovative conceptual framework to study coronavirus-host interactions and reveal new targets
for the development of novel anti-coronavirus therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nanopore-Based HIV Self-Test for Ultrasensitive p24 Quantification in FingerPrick Blood
-
批准号:10594132
-
项目类别:
-
资助金额:$41.3万
-
财政年份:2023
-
负责人:Chang Liu
-
依托单位:
ISOLATION AND IDENTIFICATION OF TWO NOVEL SDS-RESISTANT SECRETED CHITINASES
-
批准号:8361380
-
项目类别:
-
资助金额:$1.22万
-
财政年份:2011
-
负责人:Chang Liu
-
依托单位:
ISOLATION AND IDENTIFICATION OF TWO NOVEL SDS-RESISTANT SECRETED CHITINASES
-
批准号:8168754
-
项目类别:
-
资助金额:$1.13万
-
财政年份:2010
-
负责人:Chang Liu
-
依托单位:
ISOLATION AND IDENTIFICATION OF TWO NOVEL SDS-RESISTANT SECRETED CHITINASES
-
批准号:7954007
-
项目类别:
-
资助金额:$0.28万
-
财政年份:2009
-
负责人:Chang Liu
-
依托单位:
国内基金
登录
查看更多内容
3'-甲氧基葛根素生物合成途径中关键甲基转移酶基因的克隆与功能分析
-
批准号:31300258
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:黎佳
-
依托单位:
晚期妊娠维持和抑制早产中cAMP信号活化PR的作用机制研究
-
批准号:81300507
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2013
-
负责人:陈黎
-
依托单位:
3'-UTR单核苷酸多态性影响CYP8B1基因表达致胆囊胆固醇结石形成的机制研究
-
批准号:81370561
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:秦俭
-
依托单位:
异源杂交多倍化鲫鲤特有性状的转录组及后转录组水平变化规律研究
-
批准号:31360514
-
项目类别:地区科学基金项目
-
资助金额:54.0万元
-
批准年份:2013
-
负责人:罗静
-
依托单位:
HIF基因3'UTR区SNP参与胰腺癌HIF-1α表达调控的分子机制及功能研究
-
批准号:81302082
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王秀超
-
依托单位:
鼻咽癌转移相关通路分子的microRNA调控机制及3'UTR区可变剪切的作用研究
-
批准号:81372886
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:买世娟
-
依托单位:
小鼠精原干细胞中APA位点研究及3'UTR使用频率数据库构建
-
批准号:31301085
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2013
-
负责人:熊远妍
-
依托单位: